BGI-Research and Zhejiang Lab Unveil Genos Genomic Foundation Model at ICG-20
More than 100 scientists from 19 countries gathered in Hangzhou, China, for the 20th Annual Meeting of the International Conference on Genomics (ICG-20), where BGI-Research and Zhejiang Lab announced in a press release the launch of Genos, an open-source, human-centric genomic foundation model.
The model, which contains over 10 billion parameters, is designed to help individuals interpret their own genomic data and support advancements in clinical disease diagnosis and personalized medicine. The unveiling took place during the conference’s opening session, which focused on the integration of omics and artificial intelligence across life sciences.
Speakers at the event included Professor Huanming Yang of BGI Group, who emphasized global collaboration in genomics, and Dr. George Church of Harvard Medical School, who discussed the latest progress in combining omics and AI research. Dr. Jian Wang of Zhejiang Lab highlighted the role of open-source innovation in scientific discovery, while Dr. Hefeng Huang of Zhejiang University presented research on using omics technologies for early cancer prevention.
The ICG-20 meeting marked two decades of international collaboration in genomics, continuing its mission inspired by the Human Genome Project to promote shared scientific progress in the field.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types
BioMap Announces 11 AI Life Science Collaborations
Google Expands Health AI Work in Singapore
Google Gives 200 European Scientists Access to AI Models
Ultima Genomics to Sequence 80,000 Samples for UK Biobank Immune Study
Daily AI Brief: the AI news that matters, in your inbox.